{"id":970,"date":"2009-11-17T13:33:40","date_gmt":"2009-11-17T08:03:40","guid":{"rendered":"http:\/\/www.niftylivecharts.com\/blog\/?p=970"},"modified":"2009-11-17T13:33:40","modified_gmt":"2009-11-17T08:03:40","slug":"stock-updateglenmark-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.niftylivecharts.com\/blog\/stock-updateglenmark-pharmaceuticals\/","title":{"rendered":"STOCK UPDATE;Glenmark Pharmaceuticals"},"content":{"rendered":"<h2><strong> <\/strong><span style=\"color: #ff0000;\"><span style=\"text-decoration: underline;\"><strong>Glenmark Pharmaceuticals<\/strong><\/span><\/span><\/h2>\n<h3><strong>Cluster: <span style=\"color: #008000;\">Apple Green<\/span><\/strong><\/h3>\n<h3><strong>Recommendation: <span style=\"color: #008000;\">Buy<\/span><\/strong><\/h3>\n<h3><strong>Price target: <span style=\"color: #008000;\">Rs285<\/span><\/strong><\/h3>\n<h3><strong>Current market price: <span style=\"color: #008000;\">Rs230<\/span><\/strong><\/h3>\n<p><span style=\"text-decoration: underline;\"><strong>Glenmark announces some positive deals with Medicis<\/strong><\/span><br \/>\nGlenmark Pharmaceuticals (Glenmark) has made a series of announcements regarding its patent settlement (Vanos), abbreviated new drug application (ANDA) approval (Ciclopirox) and outlicencing deal (a specialty pharmaceutical product with milestone revenue of $5 million) with US-based Medicis Pharma (Medicis) for different sets of dermatology-based products. We have analysed the event on a singular basis and believe that the deals are positive in terms that Glenmark is increasing its foothold in the US market?s dermatology segment where it has about 13 products in its pipeline. However, any substantial gain from these deals is yet on the sidelines as the deal would generate meaningful revenue only after a couple of years.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals Cluster: Apple Green Recommendation: Buy Price target: Rs285 Current market price: Rs230 Glenmark announces some positive deals with Medicis Glenmark Pharmaceuticals (Glenmark) has made a series of announcements regarding its patent settlement (Vanos), abbreviated new drug application (ANDA) approval (Ciclopirox) and outlicencing deal (a specialty pharmaceutical product with milestone revenue of $5 million) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[1],"tags":[3065,3066,3067,3063,3064,3062],"class_list":["post-970","post","type-post","status-publish","format-standard","category-general","tag-current-market-update-on-glenmark-pharmaceuticals-by-sharekhan","tag-glenmark-announces-some-positive-deals-with-medicis","tag-glenmark-pharmaceuticals","tag-glenmark-pharmaceuticals-price-target-update","tag-sharekhan-updated-price-target-on-glenmark-pharmaceuticals","tag-stock-update-on-glenmark-pharmaceuticles","entry"],"_links":{"self":[{"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/posts\/970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/comments?post=970"}],"version-history":[{"count":0,"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/posts\/970\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/media?parent=970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/categories?post=970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.niftylivecharts.com\/blog\/wp-json\/wp\/v2\/tags?post=970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}